Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Stephanie F LingCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.ORCID 0000-0001-8148-2344
Chuan Fu YapCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.ORCID 0000-0001-5256-5642
Nisha NairCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.ORCID 0000-0001-9829-792X
Suzanne M M VerstappenNIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-6181-0646
John D IsaacsTranslational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.ORCID 0000-0002-6103-7056
Anthony G WilsonSchool of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland.ORCID 0000-0003-4855-3926
Kimme L HyrichNIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-8242-9262
Anne BartonCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.ORCID 0000-0003-3316-2527
Darren PlantCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.ORCID 0000-0003-1395-9344
Funding
AstraZenecaDepartment of Health 21754Health Innovation ManchesterLeeds Biomedical Research CentreManchester Academic Health Science CentreManchester Biomedical Research Centre NIHR203308Newcastle Biomedical Research Centre for Ageing and Long-Term ConditionsNHSNIHRNIHR NIHR202395Research in AWM's laboratoryResearch into Inflammatory Arthritis Centre 22072University of Leeds
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis. · full record | OpenQuestion